1. New developments in the drug treatment of glaucoma;Hurvitz, L.M.; Kaufman, P.L.; Robin, A.L.; Weinreb, R.N.; Crawford, K.; Shaw, B.;Drugs,1991
2. Aqueous flow is reduced by the alpha-adrenergic agonist, apraclonidine hydrochloride;Gharagozloo, N.Z.; Relf, S.J.; Brubaker, R.F.;Ophthalmology,2145
3. Prophylatic use of apraclonidine for intraocular pressure increase after Nd: YAG capsulotomies;Silverstone, D.E.; Brint, S.F.; Olander, K.W.; Taylor, R.B.; McCarty, G.R.; deFaller JM;Am J Ophthalmol,1992
4. New medical treatments for glaucoma;Novak, G.D.; Robin, A.L.; Derick, R.J.;Int Ophthalmol Clin,1993
5. Apraclonidine and argon laser trabeculoplasty;Holmwood, P.C.; Chase, R.D.; Krupin, T.; Rosenberg, L.F.; Ruderman, J.M.; Tallman, B.A.;Am J Ophthalmol,1992